TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Pharmacokinetics Services Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Chronic and Infectious Diseases

4.1.2 Expanding Range of Application of Pharmacokinetic Studies

4.1.3 Outsourcing of Pharmacokinetics Services to CROs

4.2 Market Restraints

4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries

4.3 Market Opportunities

4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics

4.4 Future Trend

4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services

4.5 Impact of Drivers and Restraints:

5. Pharmacokinetics Services Market - South & Central America Analysis

5.1 South & Central America Pharmacokinetics Services Market Overview

5.2 South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031

6. South & Central America Pharmacokinetics Services Market Analysis - by Drug Type

6.1 Overview

6.2 Small Molecule

6.2.1 Overview

6.2.2 Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

6.3 Large Molecule

6.3.1 Overview

6.3.2 Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

6.4 Vaccines

6.4.1 Overview

6.4.2 Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Pharmacokinetics Services Market Analysis - by Service Type

7.1 Overview

7.2 Pre-Clinical ADME and Human Studies

7.2.1 Overview

7.2.2 Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.3 PK/PD Analysis and Reporting

7.3.1 Overview

7.3.2 PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Dosing Simulations

7.4.1 Overview

7.4.2 Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.5 Risk Analysis

7.5.1 Overview

7.5.2 Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Pharmacokinetics Services Market Analysis - by Therapeutic Application

8.1 Oncology

8.1.1 Overview

8.1.2 Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.2 Infectious Diseases

8.2.1 Overview

8.2.2 Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Neurological Disorders

8.3.1 Overview

8.3.2 Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.4 Autoimmune Diseases

8.4.1 Overview

8.4.2 Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.5 Gynecological Disorders

8.5.1 Overview

8.5.2 Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.6 Cardiovascular Diseases

8.6.1 Overview

8.6.2 Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.7 Respiratory Disorders

8.7.1 Overview

8.7.2 Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Pharmacokinetics Services Market Analysis - by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview

9.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Contract Research Organization

9.2.1 Overview

9.2.2 Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Others

9.3.1 Overview

9.3.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Pharmacokinetics Services Market - Country Analysis

10.1 South & Central America

10.1.1 South & Central America Pharmacokinetics Services Market Breakdown by Countries, 2023 and 2031 (%)

10.1.1.1 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.3 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type

10.1.1.1.4 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type

10.1.1.1.5 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

10.1.1.1.6 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by End User

10.1.1.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.3 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type

10.1.1.2.4 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type

10.1.1.2.5 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

10.1.1.2.6 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by End User

10.1.1.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type

10.1.1.3.4 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type

10.1.1.3.5 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

10.1.1.3.6 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by End User

11. Company Profile

11.1 Charles River Laboratories International Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Eurofins Scientific SE

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Certara Inc.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Parexel International Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Thermo Fisher Scientific Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Allucent

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 PACIFIC BIOLABS

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 SGS SA

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms for Pharmacokinetic Services Market

List of Tables

Table 1. South & Central America Pharmacokinetics Services Market Segmentation

Table 2. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 3. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 4. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 5. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 6. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 7. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 8. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 9. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 10. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 11. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 12. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 13. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 14. Glossary of Terms

List of Figures

Figure 1. South & Central America Pharmacokinetics Services Market Segmentation, by Country

Figure 2. South & Central America Pharmacokinetics Services Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031

Figure 5. South & Central America Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)

Figure 6. Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 9. South & Central America Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)

Figure 10. Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 12. Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 15. South & Central America Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)

Figure 16. Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 21. Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. South & Central America Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)

Figure 25. Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 26. Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. South & Central America Pharmacokinetics Services Market by Key Countries - Revenue (2023) (US$ Million)

Figure 29. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 31. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)